IART logo

Integra LifeSciences Holdings (IART) Total Liabilities

Annual Total Liabilities

$2.19 B
+$108.75 M+5.21%

31 December 2023

IART Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Liabilities

$2.54 B
+$3.92 M+0.15%

30 September 2024

IART Quarterly Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

IART Total Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+5.2%+17.8%
3 y3 years+4.5%+18.7%
5 y5 years+26.7%+29.7%

IART Total Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+5.2%at high+23.7%
5 y5 yearsat high+26.7%at high+34.9%
alltimeall time-2.4%>+9999.0%at high>+9999.0%

Integra LifeSciences Holdings Total Liabilities History

DateAnnualQuarterly
Sept 2024
-
$2.54 B(+0.2%)
June 2024
-
$2.54 B(+2.4%)
Mar 2024
-
$2.48 B(+13.0%)
Dec 2023
$2.19 B(+5.2%)
$2.19 B(+1.6%)
Sept 2023
-
$2.16 B(+3.1%)
June 2023
-
$2.09 B(+1.3%)
Mar 2023
-
$2.07 B(-0.9%)
Dec 2022
$2.09 B(-0.6%)
$2.09 B(+0.1%)
Sept 2022
-
$2.08 B(-0.4%)
June 2022
-
$2.09 B(+1.7%)
Mar 2022
-
$2.06 B(-1.9%)
Dec 2021
$2.10 B(-0.1%)
$2.10 B(-2.1%)
Sept 2021
-
$2.14 B(+0.2%)
June 2021
-
$2.14 B(-3.4%)
Mar 2021
-
$2.21 B(+5.3%)
Dec 2020
$2.10 B(+11.3%)
$2.10 B(+2.2%)
Sept 2020
-
$2.06 B(+0.6%)
June 2020
-
$2.04 B(-3.0%)
Mar 2020
-
$2.11 B(+11.6%)
Dec 2019
$1.89 B(+8.9%)
$1.89 B(-3.8%)
Sept 2019
-
$1.96 B(+4.9%)
June 2019
-
$1.87 B(+3.4%)
Mar 2019
-
$1.81 B(+4.4%)
Dec 2018
$1.73 B(-23.0%)
$1.73 B(-4.5%)
Sept 2018
-
$1.81 B(-1.6%)
June 2018
-
$1.84 B(-18.0%)
Mar 2018
-
$2.25 B(+0.0%)
Dec 2017
$2.25 B(+132.3%)
$2.25 B(+49.4%)
Sept 2017
-
$1.51 B(+24.7%)
June 2017
-
$1.21 B(+0.8%)
Mar 2017
-
$1.20 B(+23.6%)
Dec 2016
$968.29 M(-5.3%)
$968.29 M(-3.6%)
Sept 2016
-
$1.00 B(-1.5%)
June 2016
-
$1.02 B(-3.3%)
Mar 2016
-
$1.05 B(+3.0%)
Dec 2015
$1.02 B(+15.8%)
$1.02 B(-6.8%)
Sept 2015
-
$1.10 B(+18.5%)
June 2015
-
$926.17 M(+7.4%)
Mar 2015
-
$862.71 M(-2.3%)
Dec 2014
$883.10 M(+67.9%)
$883.10 M(+2.7%)
Sept 2014
-
$859.76 M(-1.6%)
June 2014
-
$873.79 M(-0.3%)
Mar 2014
-
$876.72 M(+66.7%)
Dec 2013
$526.05 M(-18.5%)
$526.05 M(-23.2%)
Sept 2013
-
$684.60 M(+2.0%)
June 2013
-
$670.91 M(+3.8%)
Mar 2013
-
$646.60 M(+0.1%)
Dec 2012
$645.82 M(-0.9%)
$645.82 M(-2.0%)
Sept 2012
-
$658.80 M(+0.6%)
June 2012
-
$654.61 M(+0.7%)
Mar 2012
-
$649.92 M(-0.2%)
Dec 2011
$651.47 M(+25.9%)
$651.47 M(-3.2%)
Sept 2011
-
$673.14 M(+6.0%)
June 2011
-
$635.04 M(+32.5%)
Mar 2011
-
$479.44 M(-7.3%)
Dec 2010
$517.35 M
$517.35 M(+5.9%)
Sept 2010
-
$488.48 M(+1.5%)
June 2010
-
$481.42 M(+0.3%)
DateAnnualQuarterly
Mar 2010
-
$480.08 M(-3.1%)
Dec 2009
$495.22 M(-24.2%)
$495.22 M(-8.8%)
Sept 2009
-
$542.81 M(-0.1%)
June 2009
-
$543.60 M(-12.5%)
Mar 2009
-
$621.15 M(-5.0%)
Dec 2008
$653.71 M(+17.2%)
$653.71 M(+2.3%)
Sept 2008
-
$639.15 M(+18.7%)
June 2008
-
$538.37 M(-21.3%)
Mar 2008
-
$683.78 M(+22.6%)
Dec 2007
$557.58 M(+75.6%)
$557.58 M(-0.4%)
Sept 2007
-
$559.68 M(+1.2%)
June 2007
-
$552.98 M(+74.2%)
Mar 2007
-
$317.53 M(+0.0%)
Dec 2006
$317.46 M(+100.1%)
$317.46 M(+6.2%)
Sept 2006
-
$298.98 M(+17.6%)
June 2006
-
$254.17 M(+39.2%)
Mar 2006
-
$182.58 M(+15.1%)
Dec 2005
$158.61 M(+6.5%)
$158.61 M(+0.2%)
Sept 2005
-
$158.28 M(+0.8%)
June 2005
-
$156.99 M(+0.6%)
Mar 2005
-
$156.06 M(+4.8%)
Dec 2004
$148.89 M(+3.4%)
$148.89 M(+0.9%)
Sept 2004
-
$147.55 M(+0.3%)
June 2004
-
$147.13 M(+2.8%)
Mar 2004
-
$143.12 M(-0.6%)
Dec 2003
$144.00 M(+431.9%)
$144.00 M(-7.4%)
Sept 2003
-
$155.47 M(+0.7%)
June 2003
-
$154.45 M(+14.1%)
Mar 2003
-
$135.34 M(+400.0%)
Dec 2002
$27.07 M(+15.0%)
$27.07 M(+8.4%)
Sept 2002
-
$24.97 M(+29.8%)
June 2002
-
$19.24 M(+5.1%)
Mar 2002
-
$18.30 M(-22.2%)
Dec 2001
$23.53 M(-28.1%)
$23.53 M(-1.9%)
Sept 2001
-
$23.99 M(-24.3%)
June 2001
-
$31.67 M(-7.4%)
Mar 2001
-
$34.20 M(+4.5%)
Dec 2000
$32.73 M(+15.8%)
$32.73 M(-5.5%)
Sept 2000
-
$34.63 M(+5.5%)
June 2000
-
$32.83 M(+8.7%)
Mar 2000
-
$30.21 M(+6.9%)
Dec 1999
$28.26 M(+756.5%)
$28.26 M(+3.2%)
Sept 1999
-
$27.40 M(-4.2%)
June 1999
-
$28.60 M(+14.4%)
Mar 1999
-
$25.00 M(+657.6%)
Dec 1998
$3.30 M(+26.9%)
$3.30 M(-25.0%)
Sept 1998
-
$4.40 M(+7.3%)
June 1998
-
$4.10 M(+10.8%)
Mar 1998
-
$3.70 M(+42.3%)
Dec 1997
$2.60 M(+13.0%)
$2.60 M(-13.3%)
Sept 1997
-
$3.00 M(+30.4%)
June 1997
-
$2.30 M(+4.5%)
Mar 1997
-
$2.20 M(-4.3%)
Dec 1996
$2.30 M(+15.0%)
$2.30 M(0.0%)
Sept 1996
-
$2.30 M(+9.5%)
June 1996
-
$2.10 M(+16.7%)
Mar 1996
-
$1.80 M(-10.0%)
Dec 1995
$2.00 M
$2.00 M(-23.1%)
Sept 1995
-
$2.60 M

FAQ

  • What is Integra LifeSciences Holdings annual total liabilities?
  • What is the all time high annual total liabilities for Integra LifeSciences Holdings?
  • What is Integra LifeSciences Holdings annual total liabilities year-on-year change?
  • What is Integra LifeSciences Holdings quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Integra LifeSciences Holdings?
  • What is Integra LifeSciences Holdings quarterly total liabilities year-on-year change?

What is Integra LifeSciences Holdings annual total liabilities?

The current annual total liabilities of IART is $2.19 B

What is the all time high annual total liabilities for Integra LifeSciences Holdings?

Integra LifeSciences Holdings all-time high annual total liabilities is $2.25 B

What is Integra LifeSciences Holdings annual total liabilities year-on-year change?

Over the past year, IART annual total liabilities has changed by +$108.75 M (+5.21%)

What is Integra LifeSciences Holdings quarterly total liabilities?

The current quarterly total liabilities of IART is $2.54 B

What is the all time high quarterly total liabilities for Integra LifeSciences Holdings?

Integra LifeSciences Holdings all-time high quarterly total liabilities is $2.54 B

What is Integra LifeSciences Holdings quarterly total liabilities year-on-year change?

Over the past year, IART quarterly total liabilities has changed by +$384.07 M (+17.78%)